课题基金 / 基金详情

PHASE I/II OPEN-LABEL PHARMACOKINETIC AND SAFETY STUDY OF ZENAPAX

PHASE I/II OPEN-LABEL PHARMACOKINETIC AND SAFETY STUDY OF ZENAPAX
Zenapax 的 I/II 期开放标签药代动力学和安全性研究
批准号：
6412135
负责人：
ROBERT Bruce ETTENGER
金额：
$20.73万
依托单位：
UNIVERSITY OF CALIFORNIA LOS ANGELES
依托单位国家：
美国
项目类别：
财政年份：
2000
资助国家：
美国
项目状态：
已结题
起止时间：
2000-12-01 至 2001-11-30
来源：
https://reporter.nih.gov/project-details/6412135
关键词：
acute disease /disorder chronic disease /disorder chronic renal failure clinical research clinical trial phase I dialysis therapy drug screening /evaluation homologous transplantation human subject human therapy evaluation immunosuppressive kidney transplantation pharmacokinetics transplant rejection

项目成果

ROBERT Bruce ETTENGER的其他基金

相关文献

期刊论文(0)
专著(0)
科研奖励(0)
会议论文
A RANDOMIZED, MULTI-CENTER COMPARATIVE TRIAL OF TACROLIMUS WITH STEROIDS AND
A RANDOMIZED, MULTI-CENTER COMPARATIVE TRIAL OF TACROLIMUS WITH STEROIDS AND
A RANDOMIZED, MULTI-CENTER COMPARATIVE TRIAL OF TACROLIMUS WITH STEROIDS AND
RECOMBINANT HUMAN GROWTH HORMONE (NUTROPIN) IN POST RENAL TRANSPLANTED CHILDREN